Profile of atacicept and its potential in the treatment of systemic lupus erythematosus [Corrigendum]
Cogollo E, Silva MA, Isenberg D. Drug Design, Development and Therapy. 2015;9:1331–1339.The author list contained a spelling error: Estafania Cogollo should be Estefania Cogollo.Read the original article
Main Authors: | Cogollo E, Silva MA, Isenberg D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-03-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/corrigendum-profile-of-atacicept-and-its-potential-in-the-treatme-peer-reviewed-article-DDDT |
Similar Items
-
Profile of atacicept and its potential in the treatment of systemic lupus erythematosus
by: Cogollo E, et al.
Published: (2015-03-01) -
Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials
by: Maria Pitsiu, et al.
Published: (2023-08-01) -
Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
by: David A. Isenberg, et al.
Published: (2020-11-01) -
Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus
by: Al Rayes H, et al.
Published: (2014-11-01) -
Atacicept: targeting B cells in multiple sclerosis
by: Hans-Peter Hartung, et al.
Published: (2010-07-01)